TSLA vs. RIGL
TSLA (Tesla, Inc.) and RIGL (Rigel Pharmaceuticals, Inc.) are both stocks. TSLA operates in Auto Manufacturers (Consumer Cyclical), while RIGL operates in Biotechnology (Healthcare). Over the past 10 years, TSLA returned 39.56%/yr vs 2.33%/yr for RIGL. At a 0.22 correlation, their price movements are largely independent.
Performance
TSLA vs. RIGL - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, TSLA achieves a -9.07% return, which is significantly higher than RIGL's -29.77% return. Over the past 10 years, TSLA has outperformed RIGL with an annualized return of 39.56%, while RIGL has yielded a comparatively lower 2.33% annualized return.
TSLA
- 1D
- 4.59%
- 1M
- -4.53%
- YTD
- -9.07%
- 6M
- -6.97%
- 1Y
- 38.56%
- 3Y*
- 18.72%
- 5Y*
- 15.43%
- 10Y*
- 39.56%
RIGL
- 1D
- 0.50%
- 1M
- 15.51%
- YTD
- -29.77%
- 6M
- -30.69%
- 1Y
- 39.97%
- 3Y*
- 23.16%
- 5Y*
- -5.96%
- 10Y*
- 2.33%
TSLA vs. RIGL - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
TSLA Tesla, Inc. | -9.07% | 11.36% | 62.52% | 101.72% | -65.03% | 49.76% | 743.44% | 25.70% | 6.89% | 45.70% |
RIGL Rigel Pharmaceuticals, Inc. | -29.77% | 154.64% | 16.00% | -3.33% | -43.40% | -24.29% | 63.55% | -6.96% | -40.72% | 63.03% |
Correlation
The correlation between TSLA and RIGL is 0.12, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.12 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.16 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.21 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.20 |
Correlation (All Time) Calculated using the full available price history since Jun 29, 2010 | 0.22 |
Fundamentals
TSLA:
$1.45T
RIGL:
$592.15M
TSLA:
$1.10
RIGL:
$19.21
TSLA:
372.50
RIGL:
1.57
TSLA:
45.57
RIGL:
0.00
TSLA:
14.75
RIGL:
1.90
TSLA:
17.20
RIGL:
1.48
TSLA:
$97.88B
RIGL:
$299.77M
TSLA:
$18.66B
RIGL:
$279.95M
TSLA:
$10.48B
RIGL:
$125.80M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
TSLA vs. RIGL — Risk / Return Rank
TSLA
RIGL
TSLA vs. RIGL - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Tesla, Inc. (TSLA) and Rigel Pharmaceuticals, Inc. (RIGL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| TSLA | RIGL | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.29 | ||
| Sortino ratioReturn per unit of downside risk | +0.03 | ||
| Omega ratioGain probability vs. loss probability | 1.17 | 1.17 | -0.01 |
| Calmar ratioReturn relative to maximum drawdown | 1.29 | 0.80 | +0.49 |
| Martin ratioReturn relative to average drawdown | 3.01 | 1.41 | +1.60 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| TSLA | RIGL | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.87 | 0.58 | +0.29 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.26 | -0.07 | +0.33 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.67 | 0.03 | +0.64 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.73 | -0.13 | +0.85 |
Drawdowns
TSLA vs. RIGL - Drawdown Comparison
The maximum TSLA drawdown since its inception was -73.63%, smaller than the maximum RIGL drawdown of -99.37%. Use the drawdown chart below to compare losses from any high point for TSLA and RIGL.
Loading charts...
Drawdown Indicators
| TSLA | RIGL | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -73.63% | -99.37% | +25.74% |
Max Drawdown (1Y)Largest decline over 1 year | -29.93% | -50.08% | +20.15% |
Max Drawdown (3Y)Largest decline over 3 years | -53.77% | -57.75% | +3.98% |
Max Drawdown (5Y)Largest decline over 5 years | -73.63% | -85.24% | +11.61% |
Max Drawdown (10Y)Largest decline over 10 years | -73.63% | -86.40% | +12.77% |
Current DrawdownCurrent decline from peak | -16.52% | -97.18% | +80.66% |
Average DrawdownAverage peak-to-trough decline | -22.73% | -90.92% | +68.19% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 12.84% | 28.34% | -15.50% |
Volatility
TSLA vs. RIGL - Volatility Comparison
The current volatility for Tesla, Inc. (TSLA) is 14.26%, while Rigel Pharmaceuticals, Inc. (RIGL) has a volatility of 18.26%. This indicates that TSLA experiences smaller price fluctuations and is considered to be less risky than RIGL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| TSLA | RIGL | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 14.26% | 18.26% | -4.00% |
Volatility (6M)Calculated over the trailing 6-month period | 28.15% | 38.39% | -10.24% |
Volatility (1Y)Calculated over the trailing 1-year period | 44.60% | 69.94% | -25.34% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 58.92% | 85.50% | -26.58% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 59.14% | 82.83% | -23.69% |
Dividends
TSLA vs. RIGL - Dividend Comparison
Neither TSLA nor RIGL has paid dividends to shareholders.
Financials
TSLA vs. RIGL - Financials Comparison
This section allows you to compare key financial metrics between Tesla, Inc. and Rigel Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
TSLA vs. RIGL - Profitability Comparison
TSLA - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Tesla, Inc. reported a gross profit of 4.72B and revenue of 22.39B. Therefore, the gross margin over that period was 21.1%.
RIGL - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Rigel Pharmaceuticals, Inc. reported a gross profit of 54.21M and revenue of 58.82M. Therefore, the gross margin over that period was 92.2%.
TSLA - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Tesla, Inc. reported an operating income of 941.00M and revenue of 22.39B, resulting in an operating margin of 4.2%.
RIGL - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Rigel Pharmaceuticals, Inc. reported an operating income of 11.89M and revenue of 58.82M, resulting in an operating margin of 20.2%.
TSLA - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Tesla, Inc. reported a net income of 491.00M and revenue of 22.39B, resulting in a net margin of 2.2%.
RIGL - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Rigel Pharmaceuticals, Inc. reported a net income of 8.65M and revenue of 58.82M, resulting in a net margin of 14.7%.
Frequently Asked Questions
TSLA and RIGL have a correlation of 0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
RIGL has higher volatility (18.26%) compared to TSLA (14.26%). In terms of maximum drawdown, TSLA dropped -73.63% vs RIGL's -99.37%.
TSLA currently has the higher Sharpe Ratio (0.87 vs 0.58), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for TSLA and RIGL
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer